Clinical Trial Update: Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

A phase 3 trial evaluating the addition of Vitamin D3 to standard chemotherapy and bevacizumab for advanced or metastatic colorectal cancer has posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Colorectal Adenocarcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-03-03